JenaValve Technology

📣Reminder📣 Don’t miss today’s lunch symposium on "A Comprehensive View of TAVR for Aortic Regurgitation" at #NYValves2025! Join the conversation and hear from leading voices shaping the future of structural heart therapy. 🗓️ Thursday, June 26th 📍 iCOACH, Room 411, Summit…

Understanding Pacemaker Trends in TAVR for Aortic Regurgitation In this @cardiacinterv article, Dr. Hendrik Wienemann explores pacemaker rates in TAVR for aortic regurgitation vs stenosis, discussing clinical outcomes, predictors of conduction disturbances, and key insights from…

Aortic regurgitation presents unique diagnostic challenges. This recent Cardiac Interventions Today article offers an overview of multimodality imaging to accurately assess AR severity and guide intervention planning. Key Points: - New standards for AR quantification - LV…

The first case in the ARTIST Trial is complete! JenaValve announces the first completed case in the ARTIST Trial, a pivotal study comparing the Trilogy Heart Valve to surgery in patients at low or intermediate surgical risk. Read the full press release to learn more:…

Live at NY Valves 2025! JenaValve spotlights two live case broadcasts featuring the Trilogy Heart Valve in action, showcasing its growing role in the management aortic regurgitation. Don’t miss the details in our latest press release: jenavalve.com/jenavalves-tri… CAUTION:…

Aortic Regurgitation Redefined. At #NYValves2025, join leading voices in #Cardiology for a high-impact session on new pathways in AR care. From diagnostics to surgery, TAVR options, and the case of a randomized clinical trial, don’t miss insights from leading cardiology…

🔴 LIVE from NY Valves 2025 🔴 Don’t miss these two live case presentations on Aortic Regurgitation! ✅ Live Case 5: A Challenging TAVR Case-Jena VAD (NYP-Columbia, NY) 🕝 2:40 PM EST ✅ Live Case 9: JenaValve Native Aortic Regurgitation (Leeds General Infirmary, UK) 🕝 8:10 AM…

TAVR for Aortic Regurgitation: A Comprehensive View #NYValves2025 | 11:45 PM Sponsored by @Jenavalve Join a distinguished faculty for key insights on: ✅ Timing of AR intervention ✅ ALIGN-AR + ARTIST updates ✅ TAVR vs. Surgery ✅ Pre-procedure planning ✅ Hands-on device…

🚨 New Issue from Cardiac Interventions Today 🚨 The latest @cardiacinterv issue explores the advancing landscape of aortic regurgitation (AR), a long undertreated disease but now gaining clinical momentum. From improved diagnostic approaches to the expanding role of TAVR in…

🫀 Advancing Structural Heart Care in Pennsylvania! JenaValve is excited to participate in @Allegheny Health Network’s 25th Annual Cardiovascular Disease Symposium, joining physicians from across Pennsylvania to discuss new innovations and approach to cardiovascular disease.…

We're here at #EuroPCR! Come visit the JenaValve team on the second floor, next to Room Maillot — we’re excited to connect and share the latest on transcatheter solutions for aortic regurgitation. See you soon! 👋🫀 #EuroPCR #TAVI #JenaValve #Trilogy

The role of TAVI is expanding beyond aortic stenosis. Join us at EuroPCR to explore the latest data and expert perspectives on emerging indications of TAVR including aortic regurgitation. 📍Room Maillot 📅 Thursday, May 22nd 🕙 4:15 PM (CEST) @PCRonline #TAVI #EuroPCR…

🎉Milestone Moment in Mainz, Germany!💯 We’re thrilled to celebrate 100 Trilogy valves implanted at @UnimedizinMainz ! This achievement marks meaningful progress in offering transcatheter options for patients with severe aortic regurgitation. Thank you to the team Mainz for…

We're heading to Paris, France for #EuroPCR2025! Visit us at Booth #M15 (Level 2) to learn how we're advancing transcatheter solutions for Aortic Regurgitation with the Trilogy Heart Valve System--the only TAVI valve CE Mark approved for AR. Don't miss the chance to connect…

Calling all interventional cardiology fellows! Join us in Miami, FL at the 2025 @crfheart Fellows Course for the Academic Satellite Program: 🫀 A Step Forward in the Evolution of TAVR: TAVR for Aortic Regurgitation 📍 Room: Coral 2 | Level 2 | Coastal Convention Center,…

JenaValve is thrilled to be exhibiting at #AATS2025! 📍Visit us at Booth #626 (next to Theater #2) to learn about the ARTIST trial—a randomized study comparing TAVR with our Trilogy THV System to SAVR in patients with symptomatic, severe aortic regurgitation. 👨…

📍Seattle-bound! We are excited to attend #AATS2025 and engage with the cardiothoracic surgery community. We look forward to insightful discussions on the evolving role of TAVR for aortic regurgitation and how it impacts surgical practice. #AATS2025 #TAVR…

📣Don't Miss Out! Tomorrow is the night — the @ASE360 Live Journal Club Session will be taking a deep dive into the evolving management of Aortic Regurgitation, with a focus on the critical role of echocardiography in accurate assessment and clinical decision-making. 📅…

Presented at #GulfPCR! This recorded case showcases Trilogy implantation in an LVAD ❤️ patient with severe aortic regurgitation (AR) 🔄. Watch the expert approach to tackling this complex case! Jump to ▶️ 1:11:30 to see the JenaValve case in action! 👀🔬 bit.ly/4jeWoGN

Live Educational Session | The @ASE360 will be hosting an X-exclusive deep dive discussion on the evolving landscape of Aortic Regurgitation management. This session will complement the recent @JournalASEcho review "Noninvasive Imaging for Native Aortic Valve Regurgitation" which…